🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 22 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 24/10/2006 | 44,05 | 44,28 | 43,42 | 43,68 | -1,44% | 1,95% | 191.345 |
| 23/10/2006 | 43,04 | 44,50 | 42,67 | 44,32 | +2,78% | 4,26% | 417.394 |
| 20/10/2006 | 42,63 | 43,12 | 41,70 | 43,12 | +1,59% | 3,34% | 162.357 |
| 19/10/2006 | 43,23 | 43,23 | 42,07 | 42,45 | -1,39% | 2,68% | 66.792 |
| 18/10/2006 | 42,52 | 43,27 | 42,30 | 43,04 | +1,32% | 2,29% | 380.445 |
| 17/10/2006 | 41,62 | 42,89 | 41,02 | 42,48 | +2,44% | 4,50% | 241.198 |
| 16/10/2006 | 40,27 | 42,15 | 40,27 | 41,47 | +2,69% | 4,65% | 261.503 |
| 13/10/2006 | 40,20 | 40,72 | 39,71 | 40,39 | -0,28% | 2,51% | 71.788 |
| 12/10/2006 | 37,99 | 40,76 | 37,99 | 40,50 | +6,08% | 7,29% | 528.883 |
| 11/10/2006 | 37,95 | 38,89 | 37,62 | 38,18 | +0,00% | 3,35% | 255.438 |
| 10/10/2006 | 38,10 | 38,29 | 36,76 | 38,18 | +0,00% | 4,03% | 71.921 |
| 09/10/2006 | 37,73 | 38,63 | 37,73 | 38,18 | +0,89% | 2,38% | 132.274 |
| 06/10/2006 | 37,28 | 38,59 | 37,28 | 37,84 | +1,71% | 3,51% | 133.610 |
| 05/10/2006 | 36,31 | 38,22 | 36,31 | 37,21 | +2,47% | 5,26% | 406.521 |
| 04/10/2006 | 36,42 | 37,17 | 36,12 | 36,31 | -0,72% | 2,88% | 132.675 |
| 03/10/2006 | 36,64 | 37,06 | 35,97 | 36,57 | -0,61% | 2,96% | 106.573 |
| 02/10/2006 | 37,47 | 37,69 | 36,49 | 36,79 | -2,09% | 3,20% | 62.090 |
| 29/09/2006 | 37,32 | 37,62 | 36,87 | 37,58 | +0,70% | 2,01% | 136.335 |
| 28/09/2006 | 37,80 | 37,80 | 37,09 | 37,32 | -1,29% | 1,88% | 555.680 |
| 27/09/2006 | 38,03 | 38,03 | 37,62 | 37,80 | -0,69% | 1,08% | 229.176 |
| 26/09/2006 | 37,92 | 38,07 | 37,43 | 38,07 | +0,99% | 1,68% | 130.003 |
| 25/09/2006 | 37,95 | 38,10 | 37,47 | 37,69 | -0,89% | 1,68% | 512.159 |
| 22/09/2006 | 38,37 | 38,37 | 37,77 | 38,03 | -0,49% | 1,56% | 371.175 |
| 21/09/2006 | 38,55 | 38,59 | 38,10 | 38,22 | -0,49% | 1,26% | 49.132 |
| 20/09/2006 | 38,48 | 39,19 | 38,18 | 38,40 | -0,19% | 2,63% | 434.493 |
| 19/09/2006 | 38,74 | 38,85 | 38,03 | 38,48 | -0,19% | 2,13% | 391.746 |
| 18/09/2006 | 38,55 | 38,93 | 37,65 | 38,55 | +0,00% | 3,30% | 175.555 |
| 15/09/2006 | 37,50 | 38,63 | 36,91 | 38,55 | +2,90% | 4,59% | 295.273 |
| 14/09/2006 | 37,95 | 38,10 | 37,47 | 37,47 | -1,18% | 1,68% | 63.425 |
| 13/09/2006 | 36,94 | 38,89 | 36,94 | 37,92 | +2,22% | 5,27% | 232.889 |